- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Cost-effectiveness of Brentuximab Vedotin With Chemotherapy in Treatment of CD30-Expressing PTCLAn economic model based on the ECHELON-2 trial demonstrated cost-effectiveness of brentuximab vedotin with chemotherapy in frontline treatment of CD30-expressing peripheral T-cell lymphoma (PTCL).
Latest:
Pharmaceuticals From Development to Practice: Learnings From an Online CurriculumThis article summarizes the outcomes from a pilot online curriculum on off-label prescribing, appraising pharmaceutical information, and talking with patients about advertised medications.
Latest:
Patient Attribution: Why the Method MattersReliable identification of the physician–patient relationship is necessary for accurate evaluation. Standardization of evidence-based attribution methods is essential to improve the value of healthcare.
Latest:
Collection of Language Data and Services Provided by Health PlansHealth plans have made substantial progress in the collection of language data and many are offering options for language services.
Latest:
A Meta-analysis Update: Percutaneous Coronary InterventionsMeta-analyses of percutaneous coronary interventions in stable coronary artery disease are updated to include 2 recent large randomized controlled trials.
Latest:
Pattern of Statin Use Among 10 Cohorts of New Users From 1995 to 2004: A Register-Based Nationwide StudyOne-year persistence among new users of statins in Finland improved from 1995 to 1998, after which no substantial changes were observed up to 2004.
Latest:
Mortality, Outcomes, and Healthcare Costs in T2DM Patients at Risk for Cardiovascular DiseaseTargeting glucose control and managing cardiovascular (CV) risk factors may prevent future CV events, and have positive downstream impact by reducing costs to healthcare stakeholders.
Latest:
Cost of Care for Malignant and Benign Renal MassesMethods for better identifying malignant versus benign disease before nephrectomy could provide significant benefits to patients and payers.
Latest:
Quality Measurement of Medication Monitoring in the Meaningful Use EraShifting from claims to integrated electronic health records to calculate quality metrics will improve reported quality attributable to data capture changes, not true quality improvements.
Latest:
Assessing Electronic Health Record Implementation Challenges Using Item Response TheoryIt is unclear which barriers cause the greatest threats to the successful implementation of an electronic health record (EHR). This paper prioritizes the potential threats to EHR adoption using a novel analytic strategy: item response theory.
Latest:
Innovation in Plain SightInnovations are powering the evolution of patient-centered care, and health plans are at the center of this innovation story.
Latest:
Can Outpatient Pharmacy Data Identify Persons With Undiagnosed COPD?Algorithms based on managed care pharmacy data can efficiently identify persons at risk for undiagnosed chronic obstructive pulmonary disease.
Latest:
Feasibility of Expanded Emergency Department Screening for Behavioral Health ProblemsThis feasibility study of expanded emergency department screening identified a high prevalence of behavioral health conditions. Screening was successfully integrated into emergency visit idle times.
Latest:
Increasing Hepatitis C Screening in a Large Integrated Health System: Science and Policy in ConcertThe success of recommendations to improve screening often rests on the availability of efficacious therapies, coverage policies, and other factors that enable and justify screening.
